A Review of the Diagnosis and Treatment of Rosacea

References

• . Scheinfeld NS. Rosacea. Skinmed. 2006;5(4):191–194
   PubMedGoogle Scholar
• . Halder RM, Brooks HL, Callender VD. Acne in ethnic skin. Dermatol Clin. 2003;21(4):609–615, vii
   PubMedGoogle Scholar
• . Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184–195
   PubMedGoogle Scholar
• . Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–341
   PubMed Web of Science ®Google Scholar
• . Wilkin JK. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol. 1981;76(1):15–18
   PubMedGoogle Scholar
• . Higgins E, du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol. 1999;17(4):437–441
   PubMedGoogle Scholar
• . Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res. 1989;281(1):66–72
   PubMedGoogle Scholar
• . Greaves MW, Burova BE. Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol. 1997;8(2):91–100
   Google Scholar
• . Wilkin J, Dahl M, Detmar M,. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584–587
   PubMed Web of Science ®Google Scholar
• . Bogetti P, Boltri M, Spagnoli G, Dolcet M. Surgical treatment of rhinophyma: a comparison of techniques. Aesthetic Plast Surg. 2002;26(1):57–60
   PubMedGoogle Scholar
• . Lloyd KM. Surgical correction of rhinophyma. Arch Dermatol. 1990;126(6):721–723
   PubMedGoogle Scholar
• . Dahl MV, Katz HI, Krueger GG,. Topical metronidazole maintains remissions of rosacea. Arch Dermatol. 1998;134(6):679–683
   PubMed Web of Science ®Google Scholar
• . Bjerke JR, Nyfors A, Austad J, Rajka G. Metronidazole (Elyzol) 1% cream vs. placebo cream in the treatment of rosacea. Clin Trials J. 1989;26:187–194
   Google Scholar
• . Breneman DL, Stewart D, Hevia O, Hino PD, Drake LA. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis. 1998;61(1):44–47
   PubMed Web of Science ®Google Scholar
• . Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol. 1998;39(3):502–504
   PubMed Web of Science ®Google Scholar
• . Colón LE, Johnson LA, Gottschalk RW. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. Cutis. 2007;79(4):317–321
   PubMedGoogle Scholar
• . Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139(11):1444–1450
   PubMedGoogle Scholar
• . Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;40(6 pt 1):961–965
   PubMedGoogle Scholar
• . Weissenbacher S, Merkl J, Hildebrandt B,. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol. 2007;156(4):728–732
   PubMedGoogle Scholar
• . Chu CY. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol. 2007;21(4):484–490
   PubMedGoogle Scholar
• . Bernard LA, Cunningham BB, Al-Suwaidan S, Friedlander SF, Eichenfield LF. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. Arch Dermatol. 2003;139(2):229–231
   PubMedGoogle Scholar
• . Antille C, Saurat JH, Lübbe J. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol. 2004;140(4):457–460
   PubMedGoogle Scholar
• . Dressler-Carre M. Acne vulgaris and rosacea. In: Arcangelo VP, Peterson AM, eds. Pharmacotherapeutics in Advanced Practice: A Practical Approach. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2005
   Google Scholar
• . Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol. 2005;4(1):41–47
   PubMedGoogle Scholar
• . Carlin RB. Topical vitamin C preparation reduces erythema of rosacea. Cosmetic Dermatology. 2001:35–38
   Google Scholar
• . Shanler SD, Ondo AL. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol. 2007;143(11):1369–1371
   PubMedGoogle Scholar
• . Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A. Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol. 2005;30(6):632–635
   PubMedGoogle Scholar
• . Theobald K, Bradshaw M, Leyden J. Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea. Skinmed. 2007;6(5):221–226
   PubMedGoogle Scholar
• . Bakar O, Demirçay Z, Yuksel M, Haklar G, Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol. 2007;32(2):197–200
   PubMed Web of Science ®Google Scholar
• . Fernandez-Obregon A, Patton DL. The role of Chlamydia pneumoniae in the etiology of acne rosacea: response to the use of oral azithromycin. Cutis. 2007;79(2):163–167
   PubMedGoogle Scholar
• . Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3(7):489–496
   PubMedGoogle Scholar
• . Torresani C, Pavesi A, Manara GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol. 1997;36(12):942–946
   PubMed Web of Science ®Google Scholar
• . Bakar O, Demirçay Z, Gürbüz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol. 2004;43(2):151–154
   PubMedGoogle Scholar
• . Pye RJ, Burton JL. Treatment of rosacea by metronidazole. Lancet. 1976;1(7971):1211–1212
   PubMed Web of Science ®Google Scholar
• . Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol. 1980;102(4):443–445
   PubMedGoogle Scholar
• . Krause MH, Torricelli R, Kündig T, Trüeb RM, Hafner J. Dapsone in granulomatous rosacea. Hautarzt. 1997;48(4):246–248
   PubMedGoogle Scholar
• . Fowler JF Jr. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol. 2007;6(6):641–645
   PubMedGoogle Scholar
• . Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499–512; quiz 513–514
   PubMed Web of Science ®Google Scholar
• . Aizawa H, Niimura M. Oral spironolactone therapy in male patients with rosacea. J Dermatol. 1992;19(5):293–297
   PubMedGoogle Scholar
• . Park JH, Oh SM, Lim SS,. Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. Biochem Biophys Res Commun. 2006;351(1):146–152
   PubMedGoogle Scholar
• . Mauss J. Cyproterone therapy of papulopustular rosacea in women. Hautarzt. 1981;32(2):94–95
   PubMedGoogle Scholar
• . Spirov G, Berova N, Vassilev D. Effect of oral inhibitors of ovulation in treatment of rosacea and dermatitis perioralis in women. Australas J Dermatol. 1971;12(3):149–154
   PubMedGoogle Scholar
• . Larson AA, Goldman MP. Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser. J Drugs Dermatol. 2007;6(8):843–845
   PubMedGoogle Scholar
• . Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg. 2007;33(4):449–454
   PubMed Web of Science ®Google Scholar
• . Laqueize S, Czernieleski J, Baltas E. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Dermatol Treat. 2007;18(3):158–162
   PubMedGoogle Scholar
• . Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T, McCullough JL. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol. 2007;32(6):693–695
   PubMedGoogle Scholar
• . Yu TG, Zheng YZ, Zhu JT, Guo W. Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone. Chin J Integr Med. 2006;12(4):277–280
   PubMedGoogle Scholar